Randy Slemmon
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 8
-
- Dementia and Cognitive Impairment Research 5
- Co-authors
- Gallen Triana‐Baltzer (5 shared papers)Hartmuth C. Kolb (5 shared papers)Marc Mercken (3 shared papers)Clara Theunis (3 shared papers)Nicholas K. Proctor (1 shared paper)Erik Stomrud (1 shared paper)David Airey (1 shared paper)Jeffrey L. Dage (1 shared paper)
- Journals
- Alzheimer s & Dementia (6 papers)Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2 papers)Nature Communications (1 paper)British Journal of Clinical Pharmacology (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Randy Slemmon
14 papers receiving 518 citations
Randy Slemmon's Hit Papers
Peers
Comparison fields: 5 of 65
- Psychiatry and Mental health 245
- Physiology 408
- Neurology 91
- Biological Psychiatry 21
- Pharmacology 101
Countries citing papers authored by Randy Slemmon
This map shows the geographic impact of Randy Slemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Slemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Slemmon more than expected).
Fields of papers citing papers by Randy Slemmon
This network shows the impact of papers produced by Randy Slemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Slemmon. The network helps show where Randy Slemmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Randy Slemmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease Hit paper breakdown → | 2020 | 292 |
| 2 | 2012 | 54 | |
| 3 | 2022 | 36 | |
| 4 | 2012 | 36 | |
| 5 | 2021 | 27 | |
| 6 | 2012 | 26 | |
| 7 | 2020 | 17 | |
| 8 | 2012 | 12 | |
| 9 | 2010 | 7 | |
| 10 | 2010 | 6 | |
| 11 | 2011 | 3 | |
| 12 | 2010 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2011 | 0 |
About Randy Slemmon
Randy Slemmon is a scholar working on Physiology, Psychiatry and Mental health, Pharmacology, Molecular Biology and Oncology, having authored 15 papers that have together received 521 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Dementia and Cognitive Impairment Research (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Cancer Treatment and Pharmacology (1 paper), Computational Drug Discovery Methods (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Psychiatry and Mental health (245 citations), Physiology (408 citations), Neurology (91 citations), Biological Psychiatry (21 citations) and Pharmacology (101 citations). Randy Slemmon has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Gallen Triana‐Baltzer, Hartmuth C. Kolb, Marc Mercken, Clara Theunis, Nicholas K. Proctor, Erik Stomrud, David Airey, Jeffrey L. Dage, Shorena Janelidze and John R. Sims. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, Nature Communications, British Journal of Clinical Pharmacology and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.